{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T18:26:50Z","timestamp":1793557610194,"version":"4.5.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03319-w","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:57:39Z","timestamp":1770242259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Recent Trends in the Development and Clinical Translation of Polymer-based Targeted Therapeutic Nanoparticle"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6598-5355","authenticated-orcid":false,"given":"Chandan Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8933-0562","authenticated-orcid":false,"given":"Ratnali","family":"Bania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3486-3942","authenticated-orcid":false,"given":"Satyendra","family":"Deka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6158-8096","authenticated-orcid":false,"given":"Monika","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anroop B.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9261-7264","authenticated-orcid":false,"given":"Trishna","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5112-7216","authenticated-orcid":false,"given":"Prasenjit","family":"Maity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8650-2874","authenticated-orcid":false,"given":"Pran Kishore","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"7","key":"3319_CR1","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1039\/c2cs15344k","volume":"41","author":"N Kamaly","year":"2012","unstructured":"Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 2012M 12;41(7):2971\u20133010.","journal-title":"Chem Soc Rev"},{"issue":"9","key":"3319_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25092193","volume":"25","author":"AA Yetisgin","year":"2020","unstructured":"Yetisgin AA, Cetinel S, Zuvin M, Kosar A, Kutlu O. Therapeutic nanoparticles and their targeted delivery applications. Molecules. 2020;25(9).","journal-title":"Molecules"},{"key":"3319_CR3","doi-asserted-by":"crossref","unstructured":"Sultana A, Zare M, Thomas V, Kumar TSS, Ramakrishna S. Nano-based drug delivery systems: Conventional drug delivery routes, recent developments and future prospects. Med Drug Discov. 2022S 1;15:100134.","DOI":"10.1016\/j.medidd.2022.100134"},{"issue":"12","key":"3319_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25122866","volume":"25","author":"A Wahane","year":"2020","unstructured":"Wahane A, Waghmode A, Kapphahn A, Dhuri K, Gupta A, Bahal R. Role of lipid-based and polymer-based non-viral vectors in nucleic acid delivery for next-generation gene therapy. Molecules. 2020;25(12).","journal-title":"Molecules"},{"issue":"7","key":"3319_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/nano10071403","volume":"10","author":"B Begines","year":"2020","unstructured":"Begines B, Ortiz T, P\u00e9rez-Aranda M, Mart\u00ednez G, Merinero M, Arg\u00fcelles-Arias F, et al. Polymeric nanoparticles for drug delivery: recent developments and future prospects. Nanomaterials. 2020;10(7).","journal-title":"Nanomaterials"},{"issue":"9","key":"3319_CR6","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1021\/acs.chemrev.5b00589","volume":"116","author":"K Ulbrich","year":"2016","unstructured":"Ulbrich K, Hol\u00e1 K, \u0160ubr V, Bakandritsos A, Tu\u010dek J, Zbo\u0159il R. Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies. Chem Rev. 2016M 11;116(9):5338\u2013431.","journal-title":"Chem Rev"},{"issue":"20","key":"3319_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25204866","volume":"25","author":"E Manek","year":"2020","unstructured":"Manek E, Darvas F, Petroianu GA. Use of biodegradable, chitosan-based nanoparticles in the treatment of Alzheimer\u2019s disease. Molecules. 2020;25(20).","journal-title":"Molecules"},{"issue":"1","key":"3319_CR8","first-page":"1001","volume":"10","author":"RH Prabhu","year":"2015","unstructured":"Prabhu RH, Patravale VB, Joshi MD. Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine. 2015F 2;10(1):1001\u201318.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3319_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.nanoso.2019.100397","volume":"20","author":"S Sur","year":"2019","unstructured":"Sur S, Rathore A, Dave V, Reddy KR, Chouhan RS, Sadhu V. Recent developments in functionalized polymer nanoparticles for efficient drug delivery system. Nano-Struct Nano-Objects. 2019;20(1).","journal-title":"Nano-Struct Nano-Objects"},{"issue":"1","key":"3319_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00914037.2020.1798436","volume":"71","author":"KC de Castro","year":"2022","unstructured":"de Castro KC, Costa JM, Campos MGN. Drug-loaded polymeric nanoparticles: a review. Int J Polym Mater Polym Biomater. 2022;71(1):1\u201313.","journal-title":"Int J Polym Mater Polym Biomater"},{"issue":"1","key":"3319_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25010112","volume":"25","author":"S Bayda","year":"2020","unstructured":"Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F. The history of nanoscience and nanotechnology: from chemical\u2013physical applications to nanomedicine. Molecules. 2020;25(1).","journal-title":"Molecules"},{"issue":"28","key":"3319_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","volume":"200","author":"A Wicki","year":"2015","unstructured":"Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Controlled Release. 2015;200(28):138\u201357.","journal-title":"J Controlled Release"},{"issue":"193","key":"3319_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106688","volume":"1","author":"J Chen","year":"2024","unstructured":"Chen J, Hu S, Sun M, Shi J, Zhang H, Yu H, et al. Recent advances and clinical translation of liposomal delivery systems in cancer therapy. Eur J Pharm Sci. 2024;1(193).","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"3319_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1517\/17425241003602259","volume":"7","author":"Y Fu","year":"2010","unstructured":"Fu Y, Kao WJ. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv. 2010;7(4):429\u201344.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"3319_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12951-020-00714-2","volume":"18","author":"A Cano","year":"2020","unstructured":"Cano A, Ettcheto M, Espina M, L\u00f3pez-Machado A, Cajal Y, Rabanal F, et al. State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections. J Nanobiotechnology. 2020;18(1):156.","journal-title":"J Nanobiotechnology"},{"issue":"12","key":"3319_CR16","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1517\/17425247.2015.1071791","volume":"12","author":"S Biffi","year":"2015","unstructured":"Biffi S, Voltan R, Rampazzo E, Prodi L, Zauli G, Secchiero P. Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery. Expert Opin Drug Deliv. 2015;12(12):1837\u201349.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"3319_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40824-020-00190-7","volume":"24","author":"YK Sung","year":"2020","unstructured":"Sung YK, Kim SW. Recent advances in polymeric drug delivery systems. Biomater Res. 2020;24(1):12.","journal-title":"Biomater Res"},{"issue":"16","key":"3319_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25163731","volume":"25","author":"A Zieli\u0144ska","year":"2020","unstructured":"Zieli\u0144ska A, Carreir\u00f3 F, Oliveira AM, Neves A, Pires B, Venkatesh DN, et al. Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules. 2020;25(16).","journal-title":"Molecules"},{"issue":"2","key":"3319_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16020273","volume":"16","author":"M Hassan","year":"2024","unstructured":"Hassan M, Abdelnabi HA, Mohsin S. Harnessing the potential of PLGA nanoparticles for enhanced bone regeneration. Pharmaceutics. 2024;16(2).","journal-title":"Pharmaceutics"},{"issue":"130","key":"3319_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","volume":"1","author":"SK Golombek","year":"2018","unstructured":"Golombek SK, May JN, Theek B, Appold L, Drude N, Kiessling F, et al. Tumor targeting via EPR: Strategies to enhance patient responses. Adv Drug Deliv Rev. 2018;1(130):17\u201338.","journal-title":"Adv Drug Deliv Rev"},{"issue":"380","key":"3319_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jconrel.2025.01.060","volume":"10","author":"Y Sung","year":"2025","unstructured":"Sung Y, Choi Y, Kim ES, Ryu JH, Kwon IC. Receptor-ligand interactions for optimized endocytosis in targeted therapies. J Controlled Release. 2025;10(380):524\u201338.","journal-title":"J Controlled Release"},{"key":"3319_CR22","doi-asserted-by":"crossref","unstructured":"Stimuli-Responsive Drug Release from Smart Polymers. [cited 2025 Nov 11]. Available from: https:\/\/www.mdpi.com\/2079-4983\/10\/3\/34","DOI":"10.3390\/jfb10030034"},{"issue":"6","key":"3319_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1571","volume":"11","author":"JF Liu","year":"2019","unstructured":"Liu JF, Jang B, Issadore D, Tsourkas A. Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting. WIREs Nanomed Nanobiotechnol. 2019;11(6).","journal-title":"WIREs Nanomed Nanobiotechnol"},{"issue":"7","key":"3319_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3109\/09687688.2010.521200","volume":"27","author":"B Yu","year":"2010","unstructured":"Yu B, Tai HC, Xue W, Lee LJ, Lee RJ. Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol. 2010;27(7):286\u201398.","journal-title":"Mol Membr Biol"},{"issue":"1","key":"3319_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40824-023-00365-y","volume":"27","author":"M Narwade","year":"2023","unstructured":"Narwade M, Shaikh A, Gajbhiye KR, Kesharwani P, Gajbhiye V. Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery. Biomater Res. 2023;27(1):42.","journal-title":"Biomater Res"},{"issue":"5\u20136","key":"3319_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1515\/jmbm-2017-0027","volume":"26","author":"N Jain","year":"2017","unstructured":"Jain N, Singh VK, Chauhan S. A review on mechanical and water absorption properties of polyvinyl alcohol based composites\/films. J Mech Behav Mater. 2017;26(5\u20136):213\u201322.","journal-title":"J Mech Behav Mater"},{"issue":"1","key":"3319_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2019.08.018","volume":"120","author":"SK Prajapati","year":"2019","unstructured":"Prajapati SK, Jain A, Jain A, Jain S. Biodegradable polymers and constructs: a novel approach in drug delivery. Eur Polym J. 2019;120(1).","journal-title":"Eur Polym J"},{"issue":"1","key":"3319_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4155\/tde.14.91","volume":"6","author":"DN Kapoor","year":"2015","unstructured":"Kapoor DN, Bhatia A, Kaur R, Sharma R, Kaur G, Dhawan S. PLGA: a Unique Polymer for Drug Delivery. Ther Deliv. 2015;6(1):41\u201358.","journal-title":"Ther Deliv"},{"issue":"11","key":"3319_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nano8110920","volume":"8","author":"N Othman","year":"2018","unstructured":"Othman N, Masarudin MJ, Kuen CY, Dasuan NA, Abdullah LC, Md. Jamil SNA. Synthesis and optimization of chitosan nanoparticles loaded with l-ascorbic acid and thymoquinone. Nanomaterials. 2018;8(11).","journal-title":"Nanomaterials"},{"issue":"17","key":"3319_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/polym14173442","volume":"14","author":"C Buckley","year":"2022","unstructured":"Buckley C, Murphy EJ, Montgomery TR, Major I. Hyaluronic acid: a review of the drug delivery capabilities of this naturally occurring polysaccharide. Polymers. 2022;14(17).","journal-title":"Polymers"},{"issue":"13","key":"3319_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/polym17131750","volume":"17","author":"E Kotenkova","year":"2025","unstructured":"Kotenkova E, Kotov A, Nikitin M. Polysaccharide-based nanocarriers for natural antimicrobials: a review. Polymers. 2025;17(13).","journal-title":"Polymers"},{"key":"3319_CR32","doi-asserted-by":"publisher","unstructured":"S\u00e9h\u00e9dic D, Roncali L, Djoudi A, Buchtova N, Avril S, Ch\u00e9rel M, et al. Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells. Front Bioeng Biotechnol [Internet]. 2021F 25;8. Available from: https:\/\/www.frontiersin.org\/journals\/bioengineering-and-biotechnology\/articles\/https:\/\/doi.org\/10.3389\/fbioe.2020.602998\/full","DOI":"10.3389\/fbioe.2020.602998\/full"},{"issue":"5","key":"3319_CR33","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1021\/acs.molpharmaceut.8b01319","volume":"16","author":"F Qiu","year":"2019","unstructured":"Qiu F, Meng T, Chen Q, Zhou K, Shao Y, Matlock G, et al. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration. Mol Pharm. 2019;16(5):1958\u201370.","journal-title":"Mol Pharm"},{"issue":"1","key":"3319_CR34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ijpharm.2007.08.034","volume":"350","author":"X Song","year":"2008","unstructured":"Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q, et al. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency. Int J Pharm. 2008;350(1):320\u20139.","journal-title":"Int J Pharm"},{"issue":"6","key":"3319_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/0883911517694397","volume":"32","author":"OA Ahmed","year":"2017","unstructured":"Ahmed OA, Fahmy UA, Al-Ghamdi AS, Aljaeid BM, Aldawsari H, Fahmy O, et al. Finasteride-loaded biodegradable nanoparticles: Near-infrared quantification of plasma and prostate levels. J Bioact Compat Polym. 2017;32(6):557\u201367.","journal-title":"J Bioact Compat Polym"},{"issue":"1","key":"3319_CR36","first-page":"1","volume":"8","author":"Y Shi","year":"2018","unstructured":"Shi Y, Sun X, Zhang L, Sun K, Li K, Li Y, et al. Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice. Sci Rep. 2018;8(1):1\u20139.","journal-title":"Sci Rep"},{"issue":"3","key":"3319_CR37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/10601325.2018.1426390","volume":"55","author":"P Mishra","year":"2018","unstructured":"Mishra P, Dey RK. Co-delivery of docetaxel and doxorubicin using biodegradable PEG-PLA micelles for treatment of breast cancer with synergistic anti-tumour effects. J Macromol Sci Part A. 2018;55(3):310\u20136.","journal-title":"J Macromol Sci Part A"},{"issue":"4","key":"3319_CR38","first-page":"362","volume":"6","author":"N Sathyamoorthy","year":"2017","unstructured":"Sathyamoorthy N, Magharla D, Chintamaneni P, Vankayalu S. Optimization of paclitaxel loaded poly (\u03b5-caprolactone) nanoparticles using Box Behnken design. Beni-Suef Univ J Basic Appl Sci. 2017;6(4):362\u201373.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"3","key":"3319_CR39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.carbpol.2009.12.040","volume":"80","author":"A Dev","year":"2010","unstructured":"Dev A, Binulal NS, Anitha A, Nair SV, Furuike T, Tamura H, et al. Preparation of poly(lactic acid)\/chitosan nanoparticles for anti-HIV drug delivery applications. Carbohydr Polym. 2010;80(3):833\u20138.","journal-title":"Carbohydr Polym"},{"issue":"11","key":"3319_CR40","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1016\/j.biomaterials.2013.01.033","volume":"34","author":"C He","year":"2013","unstructured":"He C, Yin L, Tang C, Yin C. Multifunctional polymeric nanoparticles for oral delivery of TNF-\u03b1 siRNA to macrophages. Biomaterials. 2013;34(11):2843\u201354.","journal-title":"Biomaterials"},{"issue":"1","key":"3319_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ijpharm.2017.06.052","volume":"528","author":"KM El-Say","year":"2017","unstructured":"El-Say KM, El-Sawy HS. Polymeric nanoparticles: Promising platform for drug delivery. Int J Pharm. 2017;528(1):675\u201391.","journal-title":"Int J Pharm"},{"issue":"1","key":"3319_CR42","first-page":"57","volume":"5","author":"K Krishnamoorthy","year":"2015","unstructured":"Krishnamoorthy K, Mahalingam M. Selection of a Suitable Method for the Preparation of Polymeric Nanoparticles: Multi-Criteria Decision Making Approach. Adv Pharm Bull. 2015;5(1):57\u201367.","journal-title":"Adv Pharm Bull"},{"issue":"15","key":"3319_CR43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ejps.2018.10.026","volume":"127","author":"A Ziaee","year":"2019","unstructured":"Ziaee A, Albadarin AB, Padrela L, Femmer T, O\u2019Reilly E, Walker G. Spray drying of pharmaceuticals and biopharmaceuticals: critical parameters and experimental process optimization approaches. Eur J Pharm Sci. 2019;127(15):300\u201318.","journal-title":"Eur J Pharm Sci"},{"issue":"13","key":"3319_CR44","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1039\/D5NR00071H","volume":"17","author":"TG Floyd","year":"2025","unstructured":"Floyd TG, Gurnani P, Rho JY. Characterisation of polymeric nanoparticles for drug delivery. Nanoscale. 2025;17(13):7738\u201352.","journal-title":"Nanoscale"},{"issue":"5","key":"3319_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051474","volume":"19","author":"A Polchi","year":"2018","unstructured":"Polchi A, Magini A, Meo DD, Tancini B, Emiliani C. mTOR signaling and neural stem cells: the tuberous sclerosis complex model. Int J Mol Sci. 2018;19(5).","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3319_CR46","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/15548627.2015.1136769","volume":"12","author":"M Bourdenx","year":"2016","unstructured":"Bourdenx M, Daniel J, Genin E, Soria FN, Blanchard-Desce M, Bezard E, et al. Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases. Autophagy. 2016;12(3):472\u201383.","journal-title":"Autophagy"},{"issue":"1","key":"3319_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/jfb10010004","volume":"10","author":"E Calzoni","year":"2019","unstructured":"Calzoni E, Cesaretti A, Polchi A, Di Michele A, Tancini B, Emiliani C. Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J Funct Biomater. 2019;10(1).","journal-title":"J Funct Biomater"},{"key":"3319_CR48","doi-asserted-by":"publisher","unstructured":"Wypij M, J\u0119drzejewski T, Trzci\u0144ska-Wencel J, Ostrowski M, Rai M, Goli\u0144ska P. Green Synthesized Silver Nanoparticles: Antibacterial and Anticancer Activities, Biocompatibility, and Analyses of Surface-Attached Proteins. Front Microbiol. 2021A 22;12. Available from: https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/https:\/\/doi.org\/10.3389\/fmicb.2021.632505\/full","DOI":"10.3389\/fmicb.2021.632505\/full"},{"key":"3319_CR49","doi-asserted-by":"publisher","unstructured":"Mishra L, Kumari L, Sharma Y, Chahar K, Khare S, Patel P, et al. PEGylated Nanocarriers for Gene Therapy. In: Tekade RK, Jain NK, editors. PEGylated Nanocarriers in Medicine and Pharmacy [Internet]. Singapore: Springer Nature; 2025 [cited 2025 July 29]. p. 239\u201373. Available from: https:\/\/doi.org\/10.1007\/978-981-97-7316-9_8","DOI":"10.1007\/978-981-97-7316-9_8"},{"issue":"10","key":"3319_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/marc.201800917","volume":"40","author":"N Deirram","year":"2019","unstructured":"Deirram N, Zhang C, Kermaniyan SS, Johnston APR, Such GK. pH-responsive polymer nanoparticles for drug delivery. Macromol Rapid Commun. 2019;40(10).","journal-title":"Macromol Rapid Commun"},{"key":"3319_CR51","doi-asserted-by":"publisher","unstructured":"Kong N, Deng M, Sun XN, Chen YD, Sui XB. Polydopamine-Functionalized CA-(PCL-ran-PLA) Nanoparticles for Target Delivery of Docetaxel and Chemo-photothermal Therapy of Breast Cancer. Front Pharmacol [Internet]. 2018 Feb 21 [cited 2025 July 29];9. Available from: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/https:\/\/doi.org\/10.3389\/fphar.2018.00125\/full","DOI":"10.3389\/fphar.2018.00125\/full"},{"issue":"12","key":"3319_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202000171","volume":"3","author":"R Jamaledin","year":"2020","unstructured":"Jamaledin R, Makvandi P, Yiu CKY, Agarwal T, Vecchione R, Sun W, et al. Engineered microneedle patches for controlled release of active compounds: recent advances in release profile tuning. Adv Ther. 2020;3(12).","journal-title":"Adv Ther"},{"issue":"1","key":"3319_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.surfrep.2017.02.001","volume":"72","author":"H Heinz","year":"2017","unstructured":"Heinz H, Pramanik C, Heinz O, Ding Y, Mishra RK, Marchon D, et al. Nanoparticle decoration with surfactants: Molecular interactions, assembly, and applications. Surf Sci Rep. 2017;72(1):1\u201358.","journal-title":"Surf Sci Rep"},{"issue":"1","key":"3319_CR54","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijpharm.2015.04.053","volume":"488","author":"S Wanning","year":"2015","unstructured":"Wanning S, S\u00fcverkr\u00fcp R, Lamprecht A. Pharmaceutical spray freeze drying. Int J Pharm. 2015;488(1):136\u201353.","journal-title":"Int J Pharm"},{"issue":"8","key":"3319_CR55","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/17425247.2016.1178237","volume":"13","author":"I Cacciatore","year":"2016","unstructured":"Cacciatore I, Ciulla M, Fornasari E, Marinelli L, Di Stefano A. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases. Expert Opin Drug Deliv. 2016;13(8):1121\u201331.","journal-title":"Expert Opin Drug Deliv"},{"key":"3319_CR56","doi-asserted-by":"crossref","unstructured":"Sun P, Xiao Y, Di Q, Ma W, Ma X, Wang Q, et al. <p>Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme<\/p>. Int J Nanomedicine. 2020 Sept 11;15:6673\u201387.","DOI":"10.2147\/IJN.S257459"},{"key":"3319_CR57","doi-asserted-by":"crossref","unstructured":"Li H, Cong X, Tan H, Wang J, Liu H, Gao X, et al. Cationic lipid-modified PEG-PLGA nanoparticles facilitate effective dendritic cell reprogramming to alleviate T cell-mediated autoimmunity in EAE. Biomaterials. 2026;1(327).","DOI":"10.1016\/j.biomaterials.2025.123784"},{"issue":"360","key":"3319_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2025.123581","volume":"15","author":"M Rahimi","year":"2025","unstructured":"Rahimi M, Kariminezhad Z, Rondon EP, Fahmi H, Fernandes JC, Benderdour M. Chitosan nanovectors for siRNA delivery: New horizons for nonviral gene therapy. Carbohydr Polym. 2025;15(360).","journal-title":"Carbohydr Polym"},{"issue":"3","key":"3319_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030126","volume":"10","author":"V Dzmitruk","year":"2018","unstructured":"Dzmitruk V, Apartsin E, Ihnatsyeu-Kachan A, Abashkin V, Shcharbin D, Bryszewska M. Dendrimers show promise for siRNA and microRNA therapeutics. Pharmaceutics. 2018;10(3).","journal-title":"Pharmaceutics"},{"issue":"1","key":"3319_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jconrel.2011.09.059","volume":"157","author":"ND Weber","year":"2012","unstructured":"Weber ND, Merkel OM, Kissel T, Mu\u00f1oz-Fern\u00e1ndez M\u00c1. PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro. J Controlled Release. 2012;157(1):55\u201363.","journal-title":"J Controlled Release"},{"issue":"28","key":"3319_CR61","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1039\/D4PY00234B","volume":"15","author":"I Porello","year":"2024","unstructured":"Porello I, Bono N, Candiani G, Cellesi F. Advancing nucleic acid delivery through cationic polymer design: non-cationic building blocks from the toolbox. Polym Chem. 2024;15(28):2800\u201326.","journal-title":"Polym Chem"},{"issue":"49","key":"3319_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtchem.2025.103063","volume":"1","author":"G Nunziata","year":"2025","unstructured":"Nunziata G, Pollonio D, Lacroce E, Rossi F. Smart pH-Responsive polymers in biomedical Applications: Nanoparticles, hydrogels, and emerging hybrid platforms. Mater Today Chem. 2025;1(49).","journal-title":"Mater Today Chem"},{"issue":"1","key":"3319_CR63","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1039\/C6PY01365A","volume":"8","author":"F Quinn","year":"2017","unstructured":"Quinn F, Whittaker MR, Davis TP. Glutathione responsive polymers and their application in drug delivery systems. Polym Chem. 2017;8(1):97\u2013126.","journal-title":"Polym Chem"},{"issue":"7","key":"3319_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071977","volume":"15","author":"A Bhadran","year":"2023","unstructured":"Bhadran A, Shah T, Babanyinah GK, Polara H, Taslimy S, Biewer MC, et al. Recent advances in polycaprolactones for anticancer drug delivery. Pharmaceutics. 2023;15(7).","journal-title":"Pharmaceutics"},{"issue":"3","key":"3319_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/polym12030580","volume":"12","author":"X Xu","year":"2020","unstructured":"Xu X, Liu Y, Fu W, Yao M, Ding Z, Xuan J, et al. Poly(N-isopropylacrylamide)-based thermoresponsive composite hydrogels for biomedical applications. Polymers. 2020;12(3).","journal-title":"Polymers"},{"issue":"10","key":"3319_CR66","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1021\/ar2000056","volume":"44","author":"X Ma","year":"2011","unstructured":"Ma X, Zhao Y, Liang XJ. Theranostic Nanoparticles Engineered for Clinic and Pharmaceutics. Acc Chem Res. 2011;44(10):1114\u201322.","journal-title":"Acc Chem Res"},{"issue":"3","key":"3319_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030976","volume":"15","author":"I Negut","year":"2023","unstructured":"Negut I, Bita B. Polymeric micellar systems\u2014a special emphasis on \u201cSmart\u201d drug delivery. Pharmaceutics. 2023;15(3).","journal-title":"Pharmaceutics"},{"issue":"11","key":"3319_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21334","volume":"9","author":"OR Farzam","year":"2023","unstructured":"Farzam OR, Mehran N, Bilan F, Aghajani E, Dabbaghipour R, Shahgoli GA, et al. Nanoparticles for imaging-guided photothermal therapy of colorectal cancer. Heliyon. 2023;9(11).","journal-title":"Heliyon"},{"issue":"1","key":"3319_CR69","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-025-02280-3","volume":"24","author":"R Aggarwal","year":"2025","unstructured":"Aggarwal R, Sheikh A, Akhtar M, Ghazwani M, Hani U, Sahebkar A, et al. Understanding gold nanoparticles and their attributes in ovarian cancer therapy. Mol Cancer. 2025;24(1):88.","journal-title":"Mol Cancer"},{"issue":"1","key":"3319_CR70","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Liu H, Ye Y, Lei Y, Islam R, Tan S, et al. Smart nanoparticles for cancer therapy. Signal Transduct Target Ther. 2023;8(1):418.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3319_CR71","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1186\/s12951-024-02901-x","volume":"22","author":"X Ma","year":"2024","unstructured":"Ma X, Tian Y, Yang R, Wang H, Allahou LW, Chang J, et al. Nanotechnology in healthcare, and its safety and environmental risks. J Nanobiotechnology. 2024;22(1):715.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"3319_CR72","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","volume":"22","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, et al. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023;22(1):169.","journal-title":"Mol Cancer"},{"key":"3319_CR73","doi-asserted-by":"crossref","unstructured":"Sidhic J, Aswathi MK, Prasad A, Tom A, Mohan P, Sarbadhikary P, et al. Advancements in metal and metal oxide nanoparticles for targeted cancer therapy and imaging: Mechanisms, applications, and safety concerns. J Drug Deliv Sci Technol. 2025;1(105).","DOI":"10.1016\/j.jddst.2025.106622"},{"key":"3319_CR74","unstructured":"Gold nanorod-encapsulated biodegradable polymeric matrix for combined | IJN. [cited 2025 July 29]. Available from: https:\/\/www.dovepress.com\/gold-nanorod-encapsulated-biodegradable-polymeric-matrix-for-combined--peer-reviewed-fulltext-article-IJN"},{"key":"3319_CR75","doi-asserted-by":"publisher","unstructured":"Thong PQ, Huong LTT, Tu ND, Nhung HTM, Khanh L, Manh DH, et al. Multifunctional Nanocarriers of Fe3O4@PLA-PEG\/Curcumin for MRI, Magnetic Hyperthermia and Drug Delivery. Nanomed. 2022 1; Available from: https:\/\/www.tandfonline.com\/doi\/abs\/https:\/\/doi.org\/10.2217\/nnm-2022-0070","DOI":"10.2217\/nnm-2022-0070"},{"issue":"3","key":"3319_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16030327","volume":"16","author":"S Alven","year":"2024","unstructured":"Alven S, Aderibigbe BA. Chitosan-based scaffolds incorporated with silver nanoparticles for the treatment of infected wounds. Pharmaceutics. 2024;16(3).","journal-title":"Pharmaceutics"},{"issue":"12","key":"3319_CR77","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1021\/acsbiomaterials.7b00498","volume":"3","author":"SK Mishra","year":"2017","unstructured":"Mishra SK, Kannan S. Doxorubicin-Conjugated Bimetallic Silver-Gadolinium Nanoalloy for Multimodal MRI-CT-Optical Imaging and pH-Responsive Drug Release. ACS Biomater Sci Eng. 2017;3(12):3607\u201319.","journal-title":"ACS Biomater Sci Eng"},{"issue":"13","key":"3319_CR78","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.2147\/IJN.S165184","volume":"8","author":"LP Ganipineni","year":"2018","unstructured":"Ganipineni LP, Ucakar B, Joudiou N, Bianco J, Danhier P, Zhao M, et al. Magnetic targeting of paclitaxel-loaded poly(lactic-<em>co<\/em>-glycolic acid)-based nanoparticles for the treatment of glioblastoma. Int J Nanomedicine. 2018;8(13):4509\u201321.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3319_CR79","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jcis.2016.02.012","volume":"469","author":"S Bhana","year":"2016","unstructured":"Bhana S, O\u2019Connor R, Johnson J, Ziebarth JD, Henderson L, Huang X. Photosensitizer-loaded gold nanorods for near infrared photodynamic and photothermal cancer therapy. J Colloid Interface Sci. 2016;469(1):8\u201316.","journal-title":"J Colloid Interface Sci"},{"issue":"6","key":"3319_CR80","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3390\/pharmaceutics15061713","volume":"15","author":"UT Uthappa","year":"2023","unstructured":"Uthappa UT, Suneetha M, Ajeya KV, Ji SM. Hyaluronic Acid Modified Metal Nanoparticles and Their Derived Substituents for Cancer Therapy: A Review. Pharmaceutics. 2023;15(6):1713.","journal-title":"Pharmaceutics"},{"issue":"25","key":"3319_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124264","volume":"659","author":"M Yektamanesh","year":"2024","unstructured":"Yektamanesh M, Ayyami Y, Ghorbani M, Dastgir M, Malekzadeh R, Mortezazadeh T. Characterization of multifunctional \u03b2-cyclodextrin-coated Bi2O3 nanoparticles conjugated with curcumin for CT imaging-guided synergetic chemo-radiotherapy in breast cancer. Int J Pharm. 2024;659(25).","journal-title":"Int J Pharm"},{"issue":"12","key":"3319_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ma14123149","volume":"14","author":"A Zaszczy\u0144ska","year":"2021","unstructured":"Zaszczy\u0144ska A, Moczulska-Heljak M, Gradys A, Sajkiewicz P. Advances in 3D printing for tissue engineering. Materials. 2021;14(12).","journal-title":"Materials"},{"issue":"8","key":"3319_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.hybadv.2024.100365","volume":"1","author":"P Phadtare","year":"2025","unstructured":"Phadtare P, Viswapriya V, Shinde V, Mathure D, Salunke MR. Hybrid bionanocomposites as the advancements in biomedical utility. Hybrid Adv. 2025;1(8).","journal-title":"Hybrid Adv"},{"key":"3319_CR84","doi-asserted-by":"crossref","unstructured":"Gu Z, Fu J, Lin H, He Y. Development of 3D bioprinting: From printing methods to biomedical applications. Asian J Pharm Sci. 2020 Sept 1;15(5):529\u201357.","DOI":"10.1016\/j.ajps.2019.11.003"},{"issue":"7","key":"3319_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071597","volume":"18","author":"F You","year":"2017","unstructured":"You F, Eames BF, Chen X. Application of extrusion-based hydrogel bioprinting for cartilage tissue engineering. Int J Mol Sci. 2017;18(7).","journal-title":"Int J Mol Sci"},{"issue":"32","key":"3319_CR86","first-page":"356","volume":"1","author":"H Budharaju","year":"2024","unstructured":"Budharaju H, Sundaramurthi D, Sethuraman S. Embedded 3D bioprinting \u2013 An emerging strategy to fabricate biomimetic & large vascularized tissue constructs. Bioact Mater. 2024;1(32):356\u201384.","journal-title":"Bioact Mater"},{"issue":"12","key":"3319_CR87","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/adhm.201500168","volume":"4","author":"AV Do","year":"2015","unstructured":"Do AV, Khorsand B, Geary SM, Salem AK. 3D printing of scaffolds for tissue regeneration applications. Adv Healthc Mater. 2015;4(12):1742\u201362.","journal-title":"Adv Healthc Mater"},{"issue":"24","key":"3319_CR88","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpra.2020.01.002","volume":"1","author":"O Bloom","year":"2020","unstructured":"Bloom O, Goddard N, Yannoulias B, Eccles S. The successful use of a bespoke OssDsign cranial plate to reconstruct an occipital defect following excision of a recurrent epithelioid sarcoma. JPRAS Open. 2020;1(24):71\u20136.","journal-title":"JPRAS Open"},{"issue":"6","key":"3319_CR89","doi-asserted-by":"publisher","first-page":"671","DOI":"10.22603\/ssrr.2021-0252","volume":"6","author":"I Khan","year":"2022","unstructured":"Khan I, Parker SL, Bow H, Sivaganesan A, Pennings JS, Stephens BF, et al. Clinical and cost-effectiveness of lumbar interbody fusion using Tritanium posterolateral cage (vs. propensity-matched cohort of PEEK cage). Spine Surg Relat Res. 2022;6(6):671\u201380.","journal-title":"Spine Surg Relat Res"},{"issue":"380","key":"3319_CR90","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2025.01.063","volume":"10","author":"M Jiang","year":"2025","unstructured":"Jiang M, Fang H, Tian H. Latest advancements and trends in biomedical polymers for disease prevention, diagnosis, treatment, and clinical application. J Controlled Release. 2025;10(380):138\u201374.","journal-title":"J Controlled Release"},{"key":"3319_CR91","unstructured":"Jensen LG, L\u00f8vschall C, Ladehoff Thomsen AM, Valentin G, Ris\u00f8r BW, Gutierrez-Ibarluzea I, et al. HASH(0x55d594ca87a0). Wien; 2019 [cited 2025 July 30]. Available from: https:\/\/eprints.aihta.at\/1209\/"},{"key":"3319_CR92","unstructured":"SPINEMarketGroup. Oxford Performance Materials\u2019 OsteoFab\u00ae 3D Printed PEKK Technology Focus of Study Published in The Spine Journal. SPINEMarketGroup. 2020 [cited 2025 July 30]. Available from: https:\/\/thespinemarketgroup.com\/oxford-performance-materials-osteofab-3d-printed-pekk-technology-focus-of-study-published-in-the-spine-journal\/"},{"issue":"1","key":"3319_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.stlm.2021.100044","volume":"5","author":"C Guttridge","year":"2022","unstructured":"Guttridge C, Shannon A, O\u2019Sullivan A, O\u2019Sullivan KJ, O\u2019Sullivan LW. Biocompatible 3D printing resins for medical applications: a review of marketed intended use, biocompatibility certification, and post-processing guidance. Ann 3D Print Med. 2022;5(1).","journal-title":"Ann 3D Print Med"},{"issue":"12","key":"3319_CR94","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.1021\/acsbiomaterials.3c01171","volume":"9","author":"BV Slavin","year":"2023","unstructured":"Slavin BV, Ehlen QT, Costello JPI, Nayak VV, Bonfante EA, Benalc\u00e1zar Jalkh EB, et al. 3D Printing Applications for Craniomaxillofacial Reconstruction: A Sweeping Review. ACS Biomater Sci Eng. 2023;9(12):6586\u2013609.","journal-title":"ACS Biomater Sci Eng"},{"issue":"11","key":"3319_CR95","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.dental.2020.09.002","volume":"36","author":"A Kessler","year":"2020","unstructured":"Kessler A, Reichl FX, Folwaczny M, H\u00f6gg C. Monomer release from surgical guide resins manufactured with different 3D printing devices. Dent Mater. 2020;36(11):1486\u201392.","journal-title":"Dent Mater"},{"issue":"4","key":"3319_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9040433","volume":"9","author":"M Gagliardi","year":"2021","unstructured":"Gagliardi M, Ashizawa AT. The challenges and strategies of antisense oligonucleotide drug delivery. Biomedicines. 2021;9(4).","journal-title":"Biomedicines"},{"issue":"14","key":"3319_CR97","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/IJN.S177851","volume":"21","author":"CC Chuang","year":"2018","unstructured":"Chuang CC, Cheng CC, Chen PY, Lo C, Chen YN, Shih MH, et al. Gold nanorod-encapsulated biodegradable polymeric matrix for combined photothermal and chemo-cancer therapy. Int J Nanomedicine. 2018;21(14):181\u201393.","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"3319_CR98","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2217\/nnm.16.5","volume":"11","author":"N Hoshyar","year":"2016","unstructured":"Hoshyar N, Gray S, Han H, Bao G. The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction. Nanomed. 2016;11(6):673\u201392.","journal-title":"Nanomed"},{"key":"3319_CR99","doi-asserted-by":"publisher","unstructured":"Ly PD, Ly KN, Phan HL, Nguyen HHT, Duong VA, Nguyen HV. Recent advances in surface decoration of nanoparticles in drug delivery. Front Nanotechnol. 2024 Oct 11 [cited 2025 July 30];6. Available from: https:\/\/www.frontiersin.org\/journals\/nanotechnology\/articles\/https:\/\/doi.org\/10.3389\/fnano.2024.1456939\/full","DOI":"10.3389\/fnano.2024.1456939\/full"},{"issue":"1","key":"3319_CR100","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12943-025-02410-x","volume":"24","author":"P Kesharwani","year":"2025","unstructured":"Kesharwani P, Kumar V, Goh KW, Gupta G, Alsayari A, Wahab S, et al. PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy. Mol Cancer. 2025;24(1):205.","journal-title":"Mol Cancer"},{"issue":"3","key":"3319_CR101","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","volume":"86","author":"R Singh","year":"2009","unstructured":"Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215\u201323.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"3319_CR102","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12951-018-0356-z","volume":"16","author":"E S\u00e1nchez-L\u00f3pez","year":"2018","unstructured":"S\u00e1nchez-L\u00f3pez E, Ettcheto M, Egea MA, Espina M, Cano A, Calpena AC, et al. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer\u2019s disease: in vitro and in vivo characterization. J Nanobiotechnology. 2018;16(1):32.","journal-title":"J Nanobiotechnology"},{"issue":"15","key":"3319_CR103","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.nantod.2017.06.008","volume":"1","author":"S Hassan","year":"2017","unstructured":"Hassan S, Prakash G, Bal Ozturk A, Saghazadeh S, Farhan Sohail M, Seo J, et al. Evolution and clinical translation of drug delivery nanomaterials. Nano Today. 2017;1(15):91\u2013106.","journal-title":"Nano Today"},{"key":"3319_CR104","doi-asserted-by":"publisher","unstructured":"Hua S, de Matos MBC, Metselaar JM, Storm G. Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization. Front Pharmacol. 2018 July 17;9. Available from: https:\/\/www.frontiersin.org\/journals\/pharmacology\/articles\/https:\/\/doi.org\/10.3389\/fphar.2018.00790\/full","DOI":"10.3389\/fphar.2018.00790\/full"},{"issue":"18","key":"3319_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28186624","volume":"28","author":"S Malik","year":"2023","unstructured":"Malik S, Muhammad K, Waheed Y. Emerging applications of nanotechnology in healthcare and medicine. Molecules. 2023;28(18).","journal-title":"Molecules"},{"key":"3319_CR106","unstructured":"Samyang Biopharmaceuticals Corporation. A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies. clinicaltrials.gov; 2017 May [cited 2025 July 30]. Report No.: NCT01103791. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01103791"},{"issue":"11","key":"3319_CR107","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1093\/annonc\/mdx493","volume":"28","author":"MH Voss","year":"2017","unstructured":"Voss MH, Hussain A, Vogelzang N, Lee JL, Keam B, Rha SY, et al. A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma. Ann Oncol. 2017;28(11):2754\u201360.","journal-title":"Ann Oncol"},{"issue":"10","key":"3319_CR108","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1001\/jamaoncol.2018.2168","volume":"4","author":"KA Autio","year":"2018","unstructured":"Autio KA, Dreicer R, Anderson J, Garcia JA, Alva A, Hart LL, et al. Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial. JAMA Oncol. 2018;4(10):1344\u201351.","journal-title":"JAMA Oncol"},{"issue":"31","key":"3319_CR109","doi-asserted-by":"publisher","first-page":"11449","DOI":"10.1073\/pnas.1411393111","volume":"111","author":"JE Zuckerman","year":"2014","unstructured":"Zuckerman JE, Gritli I, Tolcher A, Heidel JD, Lim D, Morgan R, et al. Correlating animal and human phase Ia\/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA. Proc Natl Acad Sci. 2014;111(31):11449\u201354.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"3319_CR110","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/JTO.0b013e3181753b4b","volume":"3","author":"CJ Langer","year":"2008","unstructured":"Langer CJ, O\u2019Byrne KJ, Socinski MA, Mikhailov SM, Le\u015bniewski-Kmak K, Smakal M, et al. Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-na\u00efve advanced non-small cell lung cancer. J Thorac Oncol. 2008;3(6):623\u201330.","journal-title":"J Thorac Oncol"},{"issue":"61","key":"3319_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102144","volume":"1","author":"N Cheraga","year":"2021","unstructured":"Cheraga N, Sun NC, Huang XX, Ye Z, Xiao QR, Huang NP. Optimized rapamycin-loaded PEGylated PLGA nanoparticles: Preparation, characterization and pharmacokinetics study. J Drug Deliv Sci Technol. 2021;1(61).","journal-title":"J Drug Deliv Sci Technol"},{"issue":"8","key":"3319_CR112","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1208\/s12249-023-02705-6","volume":"24","author":"W Jiang","year":"2023","unstructured":"Jiang W, Gao X, Wang Q, Chen Y, Li D, Zhang X, et al. The Modified Exenatide Microspheres: PLGA-PEG-PLGA Gel and Zinc-Exenatide Complex Synergistically Reduce Burst Release and Shorten Platform Stage. AAPS PharmSciTech. 2023;24(8):251.","journal-title":"AAPS PharmSciTech"},{"key":"3319_CR113","doi-asserted-by":"crossref","unstructured":"Shitole AA, Sharma N, Giram P, Khandwekar A, Baruah M, Garnaik B, et al. LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer. Mater Sci Eng C. 2020 Sept 1;114:111035.","DOI":"10.1016\/j.msec.2020.111035"},{"issue":"1","key":"3319_CR114","volume":"2013","author":"I Cucinotto","year":"2013","unstructured":"Cucinotto I, Fiorillo L, Gualtieri S, Arbitrio M, Ciliberto D, Staropoli N, et al. Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time? J Drug Deliv. 2013;2013(1).","journal-title":"J Drug Deliv"},{"issue":"17","key":"3319_CR115","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.actbio.2015.01.041","volume":"15","author":"C He","year":"2015","unstructured":"He C, Yin L, Song Y, Tang C, Yin C. Optimization of multifunctional chitosan\u2013siRNA nanoparticles for oral delivery applications, targeting TNF-\u03b1 silencing in rats. Acta Biomater. 2015;15(17):98\u2013106.","journal-title":"Acta Biomater"},{"issue":"1","key":"3319_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2004.03.008","volume":"58","author":"M Bivas-Benita","year":"2004","unstructured":"Bivas-Benita M, Romeijn S, Junginger HE, Borchard G. PLGA\u2013PEI nanoparticles for gene delivery to pulmonary epithelium. Eur J Pharm Biopharm. 2004;58(1):1\u20136.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"3319_CR117","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1080\/10717544.2018.1461955","volume":"25","author":"S Fan","year":"2018","unstructured":"Fan S, Zheng Y, Liu X, Fang W, Chen X, Liao W, et al. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer\u2019s disease. Drug Deliv. 2018;25(1):1091\u2013102.","journal-title":"Drug Deliv"},{"issue":"10","key":"3319_CR118","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","volume":"27","author":"Y Nakamura","year":"2016","unstructured":"Nakamura Y, Mochida A, Choyke PL, Kobayashi H. Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? Bioconjug Chem. 2016;27(10):2225\u201338.","journal-title":"Bioconjug Chem"},{"issue":"1","key":"3319_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10010028","volume":"10","author":"RD Bachu","year":"2018","unstructured":"Bachu RD, Chowdhury P, Al-Saedi ZHF, Karla PK, Boddu SHS. Ocular drug delivery barriers\u2014role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics. 2018;10(1).","journal-title":"Pharmaceutics"},{"issue":"8","key":"3319_CR120","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/annonc\/mdl104","volume":"17","author":"MR Green","year":"2006","unstructured":"Green MR, Manikhas GM, Orlov S, Afanasyev B, Makhson AM, Bhar P, et al. Abraxane\u00ae, a novel Cremophor\u00ae-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Ann Oncol. 2006;17(8):1263\u20138.","journal-title":"Ann Oncol"},{"issue":"3","key":"3319_CR121","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ijrobp.2013.02.009","volume":"86","author":"ME Werner","year":"2013","unstructured":"Werner ME, Cummings ND, Sethi M, Wang EC, Sukumar R, Moore DT, et al. Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer. Int J Radiat Oncol. 2013;86(3):463\u20138.","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"3319_CR122","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/clpt.2009.141","volume":"86","author":"W Zamboni","year":"2009","unstructured":"Zamboni W, Strychor S, Maruca L, Ramalingam S, Zamboni B, Wu H, et al. Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies. Clin Pharmacol Ther. 2009;86(5):519\u201326.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"3319_CR123","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1021\/ml1000307","volume":"1","author":"S Pan","year":"2010","unstructured":"Pan S, Wu X, Jiang J, Gao W, Wan Y, Cheng D, et al. Discovery of NVP-LDE225, a potent and selective smoothened antagonist. ACS Med Chem Lett. 2010;1(3):130\u20134.","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"3319_CR124","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12672-025-01821-y","volume":"16","author":"M Bhange","year":"2025","unstructured":"Bhange M, Telange D. Convergence of nanotechnology and artificial intelligence in the fight against liver cancer: a comprehensive review. Discov Oncol. 2025;16(1):77.","journal-title":"Discov Oncol"},{"issue":"10","key":"3319_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16101328","volume":"16","author":"DR Serrano","year":"2024","unstructured":"Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, et al. Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine. Pharmaceutics. 2024;16(10).","journal-title":"Pharmaceutics"},{"issue":"12","key":"3319_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/nano10122514","volume":"10","author":"P Zhou","year":"2020","unstructured":"Zhou P, He J, Huang L, Yu Z, Su Z, Shi X, et al. Microfluidic high-throughput platforms for discovery of novel materials. Nanomaterials. 2020;10(12).","journal-title":"Nanomaterials"},{"issue":"7","key":"3319_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071916","volume":"15","author":"LK Vora","year":"2023","unstructured":"Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15(7).","journal-title":"Pharmaceutics"},{"issue":"1","key":"3319_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010183","volume":"14","author":"S Wang","year":"2022","unstructured":"Wang S, Di J, Wang D, Dai X, Hua Y, Gao X, et al. State-of-the-art review of artificial neural networks to predict, characterize and optimize pharmaceutical formulation. Pharmaceutics. 2022;14(1).","journal-title":"Pharmaceutics"},{"key":"3319_CR129","first-page":"179","volume-title":"Information Computing and Applications","author":"ZY Support","year":"2012","unstructured":"Support ZY, Algorithm VMC, Application I. In: Liu C, Wang L, Yang A, editors. Information Computing and Applications. Berlin, Heidelberg: Springer; 2012. p. 179\u201386."},{"issue":"188","key":"3319_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.109756","volume":"1","author":"S Aghajanpour","year":"2025","unstructured":"Aghajanpour S, Amiriara H, Esfandyari-Manesh M, Ebrahimnejad P, Jeelani H, Henschel A, et al. Utilizing machine learning for predicting drug release from polymeric drug delivery systems. Comput Biol Med. 2025;1(188).","journal-title":"Comput Biol Med"},{"key":"3319_CR131","doi-asserted-by":"crossref","unstructured":"<p>Manish Suyala *. A Review on Analysis of K-Means Clustering Machine Learning Algorithm based on Unsupervised Learning. J Artif Intell Syst. 2024 Apr 15;6(1):85\u201395.","DOI":"10.33969\/AIS.2024060106"},{"issue":"1","key":"3319_CR132","first-page":"20","volume":"2","author":"BMS Hasan","year":"2021","unstructured":"Hasan BMS, Abdulazeez AM. A Review of Principal Component Analysis Algorithm for Dimensionality Reduction. J Soft Comput Data Min. 2021;2(1):20\u201330.","journal-title":"J Soft Comput Data Min"},{"issue":"4","key":"3319_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntm.2025.100091","volume":"1","author":"NP Dalbanjan","year":"2025","unstructured":"Dalbanjan NP, Korgaonkar K, Eelager MP, Gonal BN, Kadapure AJ, Arakera SB, et al. In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications. Nano TransMed. 2025;1(4).","journal-title":"Nano TransMed"},{"key":"3319_CR134","doi-asserted-by":"crossref","unstructured":"Shakya A, Biswas M, Pal M. Chapter 9 - Classification of Radar data using Bayesian optimized two-dimensional Convolutional Neural Network. In: Srivastava PK, Gupta DK, Islam T, Han D, Prasad R, editors. Radar Remote Sensing. Elsevier; 2022;175\u201386. (Earth Observation). Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780128234570000082","DOI":"10.1016\/B978-0-12-823457-0.00008-2"},{"issue":"1","key":"3319_CR135","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1021\/acspolymersau.1c00035","volume":"2","author":"TK Patra","year":"2022","unstructured":"Patra TK. Data-driven methods for accelerating polymer design. ACS Polym Au. 2022;2(1):8\u201326.","journal-title":"ACS Polym Au"},{"issue":"3","key":"3319_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030282","volume":"18","author":"M Spanakis","year":"2025","unstructured":"Spanakis M, Tzamali E, Tzedakis G, Koumpouzi C, Pediaditis M, Tsatsakis A, et al. Artificial intelligence models and tools for the assessment of drug\u2013herb interactions. Pharmaceuticals. 2025;18(3).","journal-title":"Pharmaceuticals"},{"key":"3319_CR137","doi-asserted-by":"crossref","unstructured":"Zhou Z, Li X, Zare RN. Optimizing Chemical Reactions with Deep Reinforcement Learning. ACS Cent Sci. 2017;3(12):1337\u201344.","DOI":"10.1021\/acscentsci.7b00492"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03319-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03319-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03319-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:02:56Z","timestamp":1772233376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03319-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":137,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3319"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03319-w","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"93"}}